US$ 23.76
dihexa 8 mg · Disguised Alpha Dihexa, 500 mg, CAS No.
Description
R.et al (2023)

Phase 1: Acute Pain Management and Activity Modification (Weeks 1-2) The initial focus is on controlling pain and inflammation while protecting the injured disc from further damage

TGF-3, Transforming Growth Factor Beta 3

Thus, passive diffusion of peptides is very limited unless the peptides possess an amphipathic structure or use synthetic means to modify the lipophilicity [2,6], such as the glycosylation strategy of peptides [12]
